Pioneering Medical Innovations
Secured financing advances Instylla’s clinical trials and commercialization readiness BEDFORD, Mass., – August 15, 2023 – Instylla, Inc., a privately
Imperative Care has announced a new organizational structure designed to accelerate the company’s growth across its businesses. According to an
CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, a medical technology company developing connected innovations to elevate care for people affected by stroke and other ischemic diseases, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Zoom™ 88 Large Distal Platform (LDP) Support, a portfolio expansion of the company’s Zoom 88 Large Distal Platform.
NEWS PROVIDED BY TiE Global TiE Global Angels, led by TiE Boston, Invests $1.395M as part of a $20M Investment
Sealonix, a Bedford, MA-based developer of sealant products for abdominopelvic and orthopedic procedures, closed a $20m Series A financing.
BEDFORD, Mass., Dec. 7, 2022 /PRNewswire/ — Rejoni announced today that it has closed a $25 million Series B financing. The round was led by Catalyst Health Ventures, with continued support from Ascension Health Ventures, Delos Capital, Sparta Group, Amed Ventures, and Iyengar Capital Partners.
Financing to see Instylla through US Pivotal and other clinical trials BEDFORD, Mass., Oct. 14, 2020 /PRNewswire/ — Instylla, Inc., a privately held
Novel dual-balloon technology designed for true 360° stent apposition CAMPBELL, Calif., May 12, 2020 /PRNewswire/ — Ostial Corporation (Ostial), a private medical technology company
Seasoned Stroke Care Executive Joins a Strong Lineup of Leadership as Company Initiates Commercialization of Breakthrough Technologies CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative
Funds to Fuel Commercialization of Breakthrough Technologies in Stroke Care to Enable Improved Patient Outcomes CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc.